Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial

M. Sørensen; S. Kristensen; K. B. Lauridsen; K. Duch; L. Dreyer; R. Christensen; E. M. Hauge; A. G. Loft; M. Nyhuus Bendix Rasch; H. C. Horn; P. C. Taylor; K. R. Nielsen; L. Uhrenholt

doi:10.1136/annrheumdis-2023-eular.1928

Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial

M. Sørensen, S. Kristensen, K. B. Lauridsen, K. Duch, L. Dreyer, R. Christensen, E. M. Hauge, A. G. Loft, M. Nyhuus Bendix Rasch, H. C. Horn, P. C. Taylor, K. R. Nielsen, L. Uhrenholt

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	POS0248
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	82
Udgave nummer	Suppl. 1
Sider (fra-til)	359
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2023-eular.1928
Status	Udgivet - 1 jun. 2023
Begivenhed	EULAR 2023 European Congress of Rheumatology - Milan, Italien Varighed: 31 maj 2023 → 3 jun. 2023 https://congress.eular.org/index.cfm

Konference

Konference	EULAR 2023 European Congress of Rheumatology
Land/Område	Italien
By	Milan
Periode	31/05/2023 → 03/06/2023
Internetadresse	https://congress.eular.org/index.cfm

Adgang til dokumentet

10.1136/annrheumdis-2023-eular.1928

http://ard.bmj.com/content/82/Suppl_1/359.abstract

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Sørensen, M., Kristensen, S., Lauridsen, K. B., Duch, K., Dreyer, L., Christensen, R., Hauge, E. M., Loft, A. G., Rasch, M. N. B., Horn, H. C., Taylor, P. C., Nielsen, K. R., & Uhrenholt, L. (2023). Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial. Annals of the Rheumatic Diseases, 82(Suppl. 1), 359. Artikel POS0248. https://doi.org/10.1136/annrheumdis-2023-eular.1928

@article{b23cc4d6cce14f45bab597801236a490,

title = "Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial",

author = "M. S{\o}rensen and S. Kristensen and Lauridsen, {K. B.} and K. Duch and L. Dreyer and R. Christensen and Hauge, {E. M.} and Loft, {A. G.} and Rasch, {M. Nyhuus Bendix} and Horn, {H. C.} and Taylor, {P. C.} and Nielsen, {K. R.} and L. Uhrenholt",

year = "2023",

month = jun,

day = "1",

doi = "10.1136/annrheumdis-2023-eular.1928",

language = "English",

volume = "82",

pages = "359",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

note = "EULAR 2023 European Congress of Rheumatology ; Conference date: 31-05-2023 Through 03-06-2023",

url = "https://congress.eular.org/index.cfm",

}

Sørensen, M , Kristensen, S , Lauridsen, KB , Duch, K , Dreyer, L, Christensen, R, Hauge, EM, Loft, AG, Rasch, MNB, Horn, HC, Taylor, PC, Nielsen, KR & Uhrenholt, L 2023, 'Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial', Annals of the Rheumatic Diseases, bind 82, nr. Suppl. 1, POS0248, s. 359. https://doi.org/10.1136/annrheumdis-2023-eular.1928

Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial. / Sørensen, M.; Kristensen, S.; Lauridsen, K. B. et al.
I: Annals of the Rheumatic Diseases, Bind 82, Nr. Suppl. 1, POS0248, 01.06.2023, s. 359.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial

AU - Sørensen, M.

AU - Kristensen, S.

AU - Lauridsen, K. B.

AU - Duch, K.

AU - Dreyer, L.

AU - Christensen, R.

AU - Hauge, E. M.

AU - Loft, A. G.

AU - Rasch, M. Nyhuus Bendix

AU - Horn, H. C.

AU - Taylor, P. C.

AU - Nielsen, K. R.

AU - Uhrenholt, L.

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1136/annrheumdis-2023-eular.1928

DO - 10.1136/annrheumdis-2023-eular.1928

M3 - Conference abstract in journal

SN - 0003-4967

VL - 82

SP - 359

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - POS0248

T2 - EULAR 2023 European Congress of Rheumatology

Y2 - 31 May 2023 through 3 June 2023

ER -

Sørensen M , Kristensen S , Lauridsen KB , Duch K , Dreyer L, Christensen R et al. Exploring Tumour Necrosis Factor Inhibitor Drug Levels During Disease Activity-Guided Tapering in Patients With Inflammatory Arthritis: Secondary Analyses From The Biodopt Trial. Annals of the Rheumatic Diseases. 2023 jun. 1;82(Suppl. 1):359. POS0248. doi: 10.1136/annrheumdis-2023-eular.1928